Holen Sie sich die Stockscreener-App
0.616
2.80%
0.015
Schlusskurs vom Vortag:
$0.601
Offen:
$0.6066
24-Stunden-Volumen:
151.26K
Relative Volume:
0.41
Marktkapitalisierung:
$20.53M
Einnahmen:
$570.00K
Nettoeinkommen (Verlust:
$-26.74M
KGV:
-0.9452
EPS:
-0.6517
Netto-Cashflow:
$-33.12M
1W Leistung:
+5.07%
1M Leistung:
+3.81%
6M Leistung:
+71.47%
1J Leistung:
-60.40%
1-Tages-Spanne:
$0.601
$0.6185
1-Wochen-Bereich:
$0.58
$0.6198
52-Wochen-Spanne:
$0.2805
$1.9933
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Compare VYNE vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.616 | 20.03M | 570.00K | -26.74M | -33.12M | -0.6517 |
VRTX
Vertex Pharmaceuticals Inc
|
433.56 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.84 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.14 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.59 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.86 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Aug Final Week: Can VYNE Therapeutics Inc sustain earnings growth2026 Top Decliners & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
VYNE (VYNE) CFO has 4,007 shares withheld to cover RSU taxes - Stock Titan
VYNE Therapeutics (VYNE) CSO covers taxes with 2,876 shares - Stock Titan
VYNE (VYNE) legal chief has 4,007 shares withheld to cover RSU taxes - Stock Titan
VYNE (NASDAQ: VYNE) CEO stock withheld to cover RSU tax bill - Stock Titan
VYNE Stock Price, Quote & Chart | VYNE THERAPEUTICS INC (NASDAQ:VYNE) - ChartMill
Short Squeeze: Can VYNE Therapeutics Inc expand its profit marginsEarnings Risk Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN - Sahm
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger–VYNE, MASI, IBCP, and HCBN - Weekly Voice
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN - Benzinga
VYNE Therapeutics Stock: Merger with Yarrow Bioscience Reshapes Biotech Pipeline and Investor Landsc - AD HOC NEWS
Merger: VYNE (NASDAQ: VYNE) to combine with Yarrow; $100M financing pledged - Stock Titan
Hedge Fund Bets: What is the long term forecast for VYNE Therapeutics Inc stockProfit Target & Real-Time Buy Signal Notifications - baoquankhu1.vn
Aug Mood: Can VYNE Therapeutics Inc expand its profit marginsPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Published on: 2026-03-27 08:05:47 - baoquankhu1.vn
ETF Watch: Does VYNE Therapeutics Inc stock have upside surprise potential2026 Catalysts & Low Drawdown Momentum Ideas - baoquankhu1.vn
If You Invested $1,000 in Vyne Therapeutics Inc (VYNE) - Stock Titan
Setup Watch: What is the long term forecast for VYNE Therapeutics Inc stockEarnings Miss & Technical Confirmation Trade Alerts - baoquankhu1.vn
VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Gains Report: Will VYNE Therapeutics Inc face regulatory challenges2026 Volume Leaders & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Big Picture: What are analysts price targets for VYNE Therapeutics IncPortfolio Risk Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance - The Globe and Mail
VYNE Therapeutics Inc. Files Form 8-K: Notice of Delisting from NASDAQ and Company Information (March 11, 2026) - Minichart
VYNE Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq grants VYNE Therapeutics (VYNE) more time to fix sub-$1 share price - Stock Titan
Entry Recap: Can VYNE Therapeutics Inc sustain earnings growthOptions Play & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Aug Outlook: Can VYNE Therapeutics Inc expand its profit marginsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Dividend Watch: What is the long term forecast for VYNE Therapeutics Inc stockJuly 2025 Closing Moves & Stepwise Swing Trade Plans - baoquankhu1.vn
Vyne Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Technical Analysis: What analysts say about VYNE Therapeutics Inc stockJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
VYNE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
VYNE Should I Buy - Intellectia AI
VYNE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VYNE: Losses narrowed in 2025 as the company pivots to a merger with Yarrow and exits key R&D programs - TradingView
VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
VYNE Therapeutics (VYNE) to Release Quarterly Earnings on Thursday - Defense World
Aug Analyst Calls: Is Magnite Inc on track to beat earningsWeekly Profit Analysis & Verified Technical Signals - baoquankhu1.vn
Financial Contrast: Qualigen Therapeutics and VYNE Therapeutics - National Today
How VYNE Therapeutics Inc. stock performs in rate cut cyclesWatch List & Consistent Income Trade Recommendations - mfd.ru
Reviewing Avalo Therapeutics (NASDAQ:AVTX) and VYNE Therapeutics (NASDAQ:VYNE) - Defense World
Why is VYNE Therapeutics Inc. stock going upTrade Signal Summary & Proven Capital Preservation Methods - mfd.ru
VYNE Therapeutics Inc. (NASDAQ:VYNE) Sees Large Decline in Short Interest - Defense World
Published on: 2026-02-14 10:12:41 - mfd.ru
VYNE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
What analysts say about VYNE Therapeutics Inc. stockWeekly Stock Analysis & Accurate Intraday Trading Signals - mfd.ru
Can VYNE Therapeutics Inc. deliver consistent dividendsJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru
Published on: 2026-02-12 18:59:51 - mfd.ru
Can VYNE Therapeutics Inc. benefit from deglobalizationPortfolio Update Report & Capital Efficient Trading Techniques - mfd.ru
Published on: 2026-02-09 22:57:29 - baoquankhu1.vn
What analysts say about VYNE Therapeutics Inc stockEarnings Growth Summary & Smart Money Movement Tracker - baoquankhu1.vn
Portfolio Recap: Why is VYNE Therapeutics Inc stock going upBuy Signal & Reliable Momentum Entry Alerts - baoquankhu1.vn
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):